Summary
Serum protein binding of phenylbutazone has been measured in the rat, guinea pig, cat, rabbit and dog, and the influence on it of renal failure induced by uranyl nitrate injection has been studied. In all species a clearcut decrease in binding was observed after the occurrence of renal failure; the time course of the fall in binding correlated well with development of renal failure. In further experiments, serum protein binding of two acidic drugs (phenylbutazone, warfarin), two basic drugs (papaverine, quinidine) and one neutral drug (digitoxin) was studied in rabbits with experimental renal failure, and the results compared with those obtained in patients with acute renal failure. In the rabbits, a decrease in the binding of phenylbutazone, warfarin, papaverine and quinidine was found, whereas protein binding of digitoxin was unchanged. In man, there was a definite fall in protein binding of phenylbutazone and digitoxin, a small decrease for warfarin and papaverine, and a slight increase for quinidine.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Black, M., Arias, I. M.: Absorption, distribution, excretion and response to the drug in the presence of chronic renal failure. In: Handb. exp. Pharmacol. Ther., Vol XXVIII/3: Concepts in Biochem. Pharmacol. (ed. J. R. Gillette and J. R. Mitchell), pp. 258–271. Berlin, Heidelberg, New York: Springer 1975
Prescott, L. F.: Pathological and physiological factors affecting drug absorption, distribution, elimination and response in man. In: Handb. exp. Pharmacol. Ther., Vol. XXVIII/3: Concepts in Biochem. Pharmacol. (ed. J. R. Gillette and J. R. Mitchell), pp. 234–257. Berlin, Heidelberg, New York: Springer 1975
Reidenberg, M. M., Affrime, M.: Influence of disease on binding of drugs to plasma proteins. Ann. N. Y. Acad. Sci.226, 115–126 (1973)
Skuterud, B., Enger, E., Halvorsen, S., Jacobsen, S., Lunde, P. M. K.: Serum protein binding of quinidine and diphenylhydantoin in healthy human volunteers and in patients with chronic renal failure. In: The basis of drug therapy in man. Fifth Internat. Congr. Pharmacolog. pp. 79–80. San-Francisco: 1972
Baker, R.: Serum albumin in uremia: A clinical investigation correlated with reversible uremia in dogs. J. Urol. (Baltimore)65, 197–211 (1951)
Taylor, J. D., Richards, R. K., Davin, C. J., Asher, J.: Plasma binding of thiopental in the nephrectomized rabbit. J. Pharmacol. exp. Ther.112, 40–48 (1954)
Nilsen, O. G., Fremstad, D., Jacobsen, S.: Increased binding of quinidine to serum albumin and lipoproteins in anuric rats. Europ. J. Pharmacol.33, 131–139 (1975)
Flamenbaum, W., Huddleston, M. L., McNeil, J. S., Hamburger, R. J.: Uranyl nitrate-induced acute renal failure in the rat: Micropuncture and renal hemodynamic studies. Kidney Int.6, 408–418 (1974)
Dromgoole, S. H.: The binding capacity of albumin and renal disease. J. Pharmacol. exp. Ther.191, 318–323 (1974)
Scatchard, G.: The attraction of proteins for small molecules and ions. Ann. N. Y. Acad. Sci.51, 660–672 (1949)
Belpaire, F. M., Bogaert, M. G.: The excretion of3H-papaverine in the rat. Biochem. Pharmacol.22, 59–66 (1973)
Cramer, G., Isaksson, B.: Quantitative determination of quinidine in plasma. Scand. J. clin. Lab. Invest.15, 553–556 (1963)
Andreasen, F.: Protein binding of drugs in plasma from patients with acute renal failure. Acta pharmacol. (Kb h.)32, 417–429 (1973)
Mussche, M. M., Belpaire, F. M., Bogaert, M. G.: Plasma protein binding of phenylbutazone during recovery from acute renal failure. Europ. J. clin. Pharmacol.9, 69–71 (1975)
Olsen, G. D., Bennett, W. M., Porter, G. A.: Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin. Pharmacol. Ther.17, 677–684 (1975)
Belpaire, F. M., Bogaert, M. G., De Broe, M., Mussche, M. M.: Serum binding of quinidine in experimental acute renal failure. Pharmacology (Basel) in press
Shoeman, D. W., Azarnoff, D. L.: The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoin. Pharmacology (Basel)7, 169–177 (1972)
Rasmussen, J., Jervell, J., Storstein, L., Gjerdrum, K.: Digitoxin kinetics in patients with impaired renal function. Clin. Pharmacol. Ther.13, 6–14 (1972)
O'Malley, K., Velasco, M., Pruitt, A., McNay, J. L.: Decreased plasma protein binding of diazoxide in uremia. Clin. Pharmacol. Ther.18, 53–58 (1975)
Gugler, R., Shoeman, D. W., Huffman, D. H., Cohlmia, J. B., Azarnoff, D. L.: Pharmacokinetics of drugs in patients with the nephrotic syndrome. J. clin. Invest.55, 1182–1189 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Belpaire, F.M., Bogaert, M.G. & Mussche, M.M. Influence of acute renal failure on the protein binding of drugs in animals and in man. Eur J Clin Pharmacol 11, 27–32 (1977). https://doi.org/10.1007/BF00561784
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561784